The role of IL1β signaling in AD is well documented as a pathological factor [152] and reported to be upregulated in AD, driving astrocyte activation and neuroinflammation overall suggesting a neurotoxic contribution in AD [153, 154], potentially acting through astrocytes and neurons in our experimental model. The gene discussed is IL1B; the disease is Alzheimer disease.